Stock DOLPHMED6 DOLPHIN MEDICAL SERVICES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dolphin Medical Services Limited

Equities

DOLPHMED6

INE796B01013

Delayed Bombay S.E.
Other stock markets
 03:30:56 01/07/2024 pm IST 		5-day change 1st Jan Change
1.92 INR +2.13% Intraday chart for Dolphin Medical Services Limited +2.13% -2.04%
29/05 Dolphin Medical Services Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
14/02 Dolphin Medical Services Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 15.85 13.59 7.55 22.5 30.05 23.71
Enterprise Value (EV) 1 97.85 75.75 71.15 28.24 36.77 31.12
P/E ratio -5.25 x -1.34 x -1.92 x -7.1 x -16.6 x -19.6 x
Yield - - - - - -
Capitalization / Revenue 6.45 x 11.4 x 3.29 x 0.37 x 5.39 x 3.66 x
EV / Revenue 39.8 x 63.6 x 31 x 0.47 x 6.6 x 4.8 x
EV / EBITDA 972 x -94.8 x -23.9 x 0.53 x -35.3 x -68.2 x
EV / FCF 80 x 52.8 x -92.9 x 0.74 x -85.6 x -125 x
FCF Yield 1.25% 1.89% -1.08% 136% -1.17% -0.8%
Price to Book 0.13 x 0.12 x 0.07 x 0.21 x 0.29 x 0.23 x
Nbr of stocks (in thousands) 15,100 15,100 15,100 15,100 15,100 15,100
Reference price 2 1.050 0.9000 0.5000 1.490 1.990 1.570
Announcement Date 02/01/19 30/09/19 06/12/20 06/12/21 07/09/22 07/11/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 2.457 1.19 2.295 60.25 5.571 6.48
EBITDA 1 0.1006 -0.7988 -2.981 52.92 -1.04 -0.4561
EBIT 1 -3.243 -3.237 -3.599 52.28 -1.668 -1.083
Operating Margin -132% -272% -156.78% 86.78% -29.93% -16.72%
Earnings before Tax (EBT) 1 -3.347 -10.28 -3.643 -2.957 -1.762 -1.176
Net income 1 -2.979 -10.05 -3.851 -3.122 -1.875 -1.246
Net margin -121.28% -844.41% -167.79% -5.18% -33.65% -19.23%
EPS 2 -0.2000 -0.6700 -0.2600 -0.2100 -0.1200 -0.0800
Free Cash Flow 1 1.224 1.435 -0.7661 38.3 -0.4293 -0.2497
FCF margin 49.81% 120.58% -33.38% 63.56% -7.71% -3.85%
FCF Conversion (EBITDA) 1,216.17% - - 72.37% - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 02/01/19 30/09/19 06/12/20 06/12/21 07/09/22 07/11/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 82 62.2 63.6 5.74 6.72 7.41
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 814.9 x -77.82 x -21.33 x 0.1084 x -6.462 x -16.26 x
Free Cash Flow 1 1.22 1.44 -0.77 38.3 -0.43 -0.25
ROE (net income / shareholders' equity) -2.41% -8.6% -3.5% -2.93% -1.8% -1.22%
ROA (Net income/ Total Assets) -0.96% -1.04% -1.25% 21.6% -0.85% -0.55%
Assets 1 311.4 968.5 307.1 -14.43 220.9 224.6
Book Value Per Share 2 8.070 7.410 7.150 6.950 6.820 6.740
Cash Flow per Share 2 0 0 0.0100 0.0200 0.0100 0.0100
Capex - - 0.35 - - -
Capex / Sales - - 15.43% - - -
Announcement Date 02/01/19 30/09/19 06/12/20 06/12/21 07/09/22 07/11/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DOLPHMED6 Stock
  4. Financials Dolphin Medical Services Limited